Lithocholic acid, a secondary bile acid, was found to exert cytostatic effects and reduce the metastatic potential of BC cells by inhibiting the epithelial-mesenchymal transition (EMT) and vascular endothelial growth factor (VEGF) expression. The gene discussed is VEGFA; the disease is breast cancer.